179 results on '"Norda R"'
Search Results
2. Can we make the predonation screening process more effective?
3. Sexual risk behaviour and donor deferral in Europe
4. World apheresis registry 2003–2007 data
5. Use of plasma: Clinical indications and types of plasma components in Sweden
6. AN EVALUATION OF THE BLOOD DONOR HEALTH QUESTIONNAIRE (DHQ) IN SWEDEN 2012: 2A-S05-05
7. Resolution of Discrepancies Between Two Microcolumn Techniques for Antibody Screening in the Uppsala Region, Sweden: SP260
8. PANORAMA OF ADVERSE EVENTS DURING CYTAPHERESIS: O127 (S.4-5)
9. CHANGING FROM PERMANENT TO TEMPORARY DEFERRAL FROM BLOOD DONATION AFTER RISK BEHAVIOR - A MODEL FOR EVALUATING RISK OF TRANSFUSION TRANSMITTED HIV, HEPATITIS B AND HEPATITIS C IN A SWEDISH SETTING: 4C-S28–03
10. Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma
11. Regional Proficiency Testing Scheme (PTS) for Column Agglutination Technology: 11 Years Experience: AP16
12. PX2: A NEW BLOOD GROUP ANTIGEN WITH IMPLICATIONS FOR TRANSFUSION RECOMMENDATIONS IN P1K AND P2K INDIVIDUALS: 4A-S16–04
13. Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma
14. OUTCOME AMONG RECIPIENTS OF PLASMA FROM FEMALE DONORS-A REGISTER-BASED COHORT STUDY: 2C-S06-02
15. World apheresis association—world apheresis registry
16. Biobanks of blood from donors and recipients of blood products
17. Unexpected effects of donor gender on the storage of liquid plasma
18. SURVIVAL AFTER BLOOD TRANSFUSION - A STUDY OF MORE THAN ONE MILLION TRANSFUSION RECIPIENTS: 4PS-29-02
19. Regarding the article “Costs associated with blood transfusion in Sweden – the societal cost of autologous, allogeneic and perioperative RBC transfusion”
20. THE ROLE OF AN INTERNATIONAL APHERESIS REGISTRY FOR THE ESTABLISHMENT OF APHERESIS THERAPY.: P51
21. World Apheresis Registry
22. Diagnosis and procedure-specific survival among transfusion of recipients in 1993 and 2000, Örebro County, Sweden
23. Adverse events and problems in therapeutic hemapheresis. A report from the Swedish registry
24. Apheresis registry in Sweden: scope, techniques and indications for treatment. A report from the Swedish apheresis study group
25. A European survey on donor deferral for allergy:Rationale and initial results of a survey in 35 countries
26. A European survey on donor deferral for allergy: Rationale and initial results of a survey in 35 countries
27. Epidemiology of massive transfusion:A BI-national study from Sweden and Denmark
28. Adverse events in apheresis : an update of the WAA registry data
29. Adverse events in apheresis: An update of the WAA registry data
30. Searching for unknown transfusion-transmitted hepatitis viruses: a binational cohort study of 1.5 million transfused patients.
31. Vox sanguinis / Biobanks of blood from donors and recipients of blood products
32. Vox sanguinis / Logistics of platelet concentrateses
33. An Evaluation Of The Blood Donor Health Questionnaire (Dhq) In Sweden 2012
34. Panorama of adverse events during cytapheresis
35. World apheresis registry 2003-2007 data.
36. Panorama of adverse events during cytapheresis
37. Unexpected effects of donor gender on the storage of liquid plasma.
38. Regarding the article 'costs associated with blood transfusion in Sweden - the societal cost of autologous, allogeneic and perioperative RBC transfusion'.
39. World apheresis association--world apheresis registry.
40. World apheresis registry
41. World Apheresis Registry (abstract P165)
42. Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma
43. Plasma exchange as rescue therapy in multiple organ failure including acute renal failure
44. Risk of Gastric Cancer and Peptic Ulcers in Relation to ABO Blood Type: A Cohort Study
45. 36 Report of World Apheresis Association registry data until June 2010
46. Adverse events and problems in therapeutic hemapheresis. A report from the Swedish registry
47. Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multicenter study.
48. In vitro Lymphoproliferative Assays with HgCl2 Cannot Identify Patients with Systemic Symptoms Attributed to Dental Amalgam
49. Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis : A Swedish multi-center study
50. Logistics of platelet concentrateses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.